Stock Report

Download full stock data and analysis for free Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Claris Lifesciences Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 533288

₹396.55

up-down-arrow ₹-0.25 (-0.06%)

As on 14-Mar-2018IST

Market cap

info icon

₹2,164 Cr

Revenue (TTM)

info icon

₹-- Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -52.06 -54.56 -46.32 -72.11 -55.15
EBIT -13.37 22.28 16.87 -186.78 -179.98
Net Profit 119.49 274.24 205.69 -29.98 -14.41
EPS -117.25 -1,808.92 2,082.68 125.83 77.81
Book Value -- -- -2.40 -354.85 -141.75
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-21Mar-20Mar-19
EBIT-Margin info --28.18------
Net Margin info --20.60------
Return on equity info 0.003.420.000.000.00
Return on Capital info -16.57-5.98-2.88-6.46-44.11
Return on Assets info -41.45-23.66-5.93-59.40-62.45
Debt to Equity (x) info -----1.80-1.84-4.33

Profitability

View Detailed Peer Comparison

ROCE

-2.88

Lower than Peers by 14.77

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
-2.88
-6.46
-44.11
5.45
18.09
Peer Median
11.89
12.20
15.46
15.21
--
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
3.05
14.03
Peer Median
13.43
10.09
12.97
9.89
--
ROA

-5.93

Lower than Peers by 12.96

Profit after tax / Average Total assets * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
-5.93
-59.40
-62.45
1.74
7.74
Peer Median
7.03
5.74
5.99
5.28
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
31.23
25.12
Peer Median
16.50
13.87
14.56
14.68
--
Net Margin

-661.02

Lower than Peers by 671.51

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
-661.02
-1,091.55
-98.22
25.85
15.34
Peer Median
10.49
8.84
10.39
9.44
--
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
33.84
19.13
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
-100.00
-94.71
556.78
Peer Median
13.45
3.43
11.25
8.37
--
EBIT Growth

78.42

Higher than Peers by 60.15

Year on year growth in operating profit (EBIT)

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
78.42
88.33
-186.25
-93.42
293.12
Peer Median
18.27
3.48
28.31
22.09
--
Net Profit Growth

94.55

Higher than Peers by 67.35

Year on year growth in profit after tax

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
94.55
33.09
-148.14
-88.56
158.17
Peer Median
27.20
-8.07
24.50
9.35
--
EPS Growth

94.56

Higher than Peers by 78.27

Year on year growth in earnings per share

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
94.56
33.08
-144.07
-84.54
378.75
Peer Median
16.28
-5.54
24.50
5.26
--
Book Value Growth

-2.40

--

Year on year growth in book value per share

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
-2.40
-78.62
-1,005.14
-99.93
10.92
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

-1.80

Lower than Peers by 1.95

Total debt / Net worth

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
-1.80
-1.84
-4.33
--
0.02
Peer Median
0.15
0.26
0.29
0.29
--
Short term debt to equity ratio

-1.80

--

(Short term borrowings / Net worth)

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
-1.80
-1.84
-4.33
--
--
Peer Median
--
--
--
--
--
Current Ratio

0.16

Lower than Peers by 1.72

Current Assets / Current Liabilities and Provisions

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
0.16
0.17
0.21
0.24
2.15
Peer Median
1.89
1.74
1.79
1.68
--
Quick Ratio

0.16

Lower than Peers by 1.48

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
0.16
0.17
0.21
0.24
2.15
Peer Median
1.64
1.32
1.39
1.25
--
Interest Coverage

-681.50

Lower than Peers by 696.88

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
-681.50
-452.59
--
--
5.38
Peer Median
15.38
12.04
13.34
10.92
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
1.26
2.07
Peer Median
20.72
22.06
19.56
23.15
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
0.05
0.50
Peer Median
0.61
0.51
0.69
0.73
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
73.78
38.72
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
--
--
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
127.31
15.91
Peer Median
60.11
64.03
23.97
31.85
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
3,071.96
1.71
Peer Median
3.92
3.87
2.47
2.93
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
--
0.62
Peer Median
0.56
0.61
0.79
0.56
--
EV/EBITDA

-275.51

Lower than Peers by 301.45

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
-275.51
-75.29
-16.83
75.97
6.62
Peer Median
25.94
28.78
21.97
23.55
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-21
Mar-20
Mar-19
Mar-18
Mar-17
Claris Lifesciences
--
--
--
2,164
1,749
Peer Median
13,501
14,139
8,549
10,579
--
loading...
loading...
loading...
loading...
loading...